Skip to content

Transthoracoscopic Sympathectomy T-3 and T-4 in moderate palmar Hyperhidrosis .

Transtoracoscopic Sympathectomy T-3 and T-4 in moderate palmar Hyperhidrosis .

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
RPCEC
Registry ID
RPCEC00000154
Enrollment
100
Registered
2013-05-24
Start date
2006-10-27
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palmar Hyperhidrosis

Interventions

Study group (Surgery): Section of the dorsal sympathetic nerve at T3-T4 level, in each hemithorax . It is performed, using only one port, in axillary region, doing minimum access techniques. It is not

Sponsors

Minimal Access Surgery National Centre
Lead Sponsor
Calixto Garcia Hospital
Collaborator

Eligibility

Sex/Gender
All
Age
16 Years to 45 Years

Inclusion criteria

Inclusion criteria: - Grade II or moderate Hiperhidrosis.

Exclusion criteria

Exclusion criteria: - Grades I or III. - Associate illnesses that impede the application of some of the - proposed interventions - Patient does not acept participate in this investigation ( patient recive all information concerning the desease, treatment,and the investigation and after that, they do not acept). - Less than 16 years old or more than 45 años.

Design outcomes

Primary

MeasureTime frame
1. Palmar sudation, (was eliminated, improved, was unchanged or became worse): at the end of treatment, 6 months and 12 months after treatment

Secondary

MeasureTime frame
1- Physical limitation: (appearance or not from compensatory sweating, thermal disregulation or Claude-Bernard-Horner syndrome as adverse events in mayor o minor degree (no, slight, moderate, severe). Measurement time: at the end of the treatment, immediately, 6 month and 12 months after treatment. 2- Psychological limitation (no, slight, moderate, severe) Measurement time: at the end of the treatment, immediately, 6 month and 12 months after treatment. 3- Complications: (Neumothorax, Hemothorax, Loco-regional sepsis and persistent pain). Measurement time: at the end of the treatment, immediately, 6 month and 12 months after treatment. 4- Cost/utility. Measurement time: 1 year after treatment. 5- Psychological test (SRDARE, Prueba de Zung y Conie). Measurement time: Previus and postreatment for each group.

Countries

Cuba

Contacts

Public ContactJosé Hernández Gutiérrez

Minimal Access Surgery National Centre

jose@cce.sld.cu

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Aug 15, 2026